ImmuPharma Market Cap

ImmuPharma has a market cap or net worth of 12.97 million as of May 29, 2025. Its market cap has increased by 38.40% in one year.

Market Cap

12.97M

Enterprise Value

12.73M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

2.60

Market Cap Chart

Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 12.97M, a decrease of -64.09%. That is a compound annual growth rate of -5.17%.

Market Cap History

Date	Market Cap	% Change
May 29, 2025	12.97M	158.42%
Dec 31, 2024	5.02M	-27.71%
Dec 29, 2023	6.94M	13.16%
Dec 30, 2022	6.13M	-62.85%
Dec 31, 2021	16.51M	-50.56%
Dec 31, 2020	33.40M	24.75%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	161.05B
GSK plc	58.67B
Haleon	37.38B
Smith & Nephew	9.31B
ConvaTec Group	5.76B
Hikma Pharmaceuticals	4.73B
HUTCHMED (China)	1.70B
Genus	1.34B

Market Cap Rankings